Atlanta, Georgia
CNS trials open to children and teens in Atlanta, GA
12 CNS studies open to children and teens are recruiting participants at sites in Atlanta as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Atlanta at a glance
- 12 studies are recruiting at a site in Atlanta.
- By phase: Phase 3 (8), Phase 4 (2), No phase (2). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (10), university, hospital or other (2).
- By research area: Schizophrenia (4), ADHD (3), Depression (3), Migraine (2).
- Most recent update to one of these records: November 12, 2026.
ADHD studies recruiting in Atlanta
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study sites
- Advanced Discovery Research LLC · Clinical Integrative Research Center of Atlanta
- Registry record
- NCT04781140 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Atlanta, GA on ClinicalTrials.gov.
Depression studies recruiting in Atlanta
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- CenExeli Research LLC
- Registry record
- NCT06372964 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Peachford Hospital-Atlanta Behavioral Research
- Registry record
- NCT07227454 · updated
Mechanisms of Behavioral Activation (BA)
- No phase
- Ages 15 to 17
- All sexes
- Sponsor
- Emory University
- Study sites
- Child and Adolescent Mood Program (CAMP) · Emory University · Facility for Education and Research in Neuroscience (FERN)
- Registry record
- NCT05548244 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Atlanta, GA on ClinicalTrials.gov.
Migraine studies recruiting in Atlanta
Responding With Evidence and Access for Childhood Headaches
- No phase
- Ages 10 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Clinical Integrative Research Center of Atlanta, Inc
- Registry record
- NCT05889624 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study sites
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134 · Rare Disease Research /ID# 231046
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Atlanta, GA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Atlanta
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Atlanta Center for Medical Research
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Atlanta Center for Medical Research
- Registry record
- NCT07424404 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Atlanta Center for Medical Research · CenExeli Research LLC
- Registry record
- NCT06229210 · updated
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT05648591 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Atlanta, GA on ClinicalTrials.gov.
Ask about studies near Atlanta
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Georgia
All Georgia locations
20 studies recruiting across 9 cities.
Decatur
6 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections